Listen as FDA Commissioner, Dr. Marty Makary, speaks with Dr. George Tidmarsh, the new Director of FDA’s Center for Drug Evaluation and Research about the future of drug regulation at the FDA.

FDA Direct, Ep. 12 – From Menopause to Food Safety: FDA's Latest Regulatory Priorities

It’s been 100 days since the new FDA Commissioner took the helm — now it’s time to answer your questions and share what’s been going on behind the scenes. In this episode, we break down how science, common sense, and transparency are shaping the FDA’s work every day.

Listen to our latest insightful conversation on FDA Direct as we explore the evolving landscape of medical device regulation and innovation.

In this episode of FDA Direct, we recap highlights for the week: Commissioner Makary at the BIO Conference, continued CEO Forums in Boston, and the latest on priority review vouchers. Tune in for key updates shaping innovation and public health.

Dr. Makary shares his five key 'Big Buckets'—the top priorities he believes are essential for a new FDA.

This Week in FDA Direct: Highlights include the FDA’s AI rollout, the discussions from the Infant Formula Expert Panel, insights from the Cell and Gene Therapy Roundtable, and takeaways from our first CEO Forum. Stay informed with the discussions shaping the future of public health and innovation.

This episode of FDA Direct discusses the latest on COVID-19 vaccines.

Missed our expert panel on talc? Don’t sweat it.

We are recapping it with our latest discussion to get you up to speed on this critical issue—one that could impact the health and lives of countless Americans.

To boost or not to boost?

COVID-19 vaccinations remain at the forefront of public conversation and this FDA is committed to bringing you answers. Join us as we dive deeper into how science—and solid evidence—will guide the path forward.